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Routine blood glucose monitoring by patients with Type 2 diabetes mellitus (T2DM) is 
needed for effective management of T2DM; however, 75% of monitoring logs are 
returned incomplete during monthly provider follow-up appointments. As a result, 
effective management of the patient’s medical condition is limited. To better understand 
the reasons for noncompliance, a quality improvement project (QIP) was initiated 
between July 01, 2017 and September 30, 2017, to identify barriers that prevented 
patients from self-monitoring of blood glucose (SMBG). No formal assessment of the 
patients’ responses had been done, and, as a result, the deidentified, qualitative responses 
from the QIP were obtained for this project. The purpose of this project was to explore 
barriers to SMBG and to use a literature search to identify strategies for improving 
compliance with SMBG. The health belief model was the framework used to guide the 
project. Secondary data obtained from the QIP (n = 19) were analyzed and coded. Results 
indicated that patients’ financial concerns, social support, emotional needs, and lack of 
diabetes education were the main barriers to daily SMBG. Recommendations to the 
providers were to consider each barrier before ordering the use and frequency of SMBG 
and to consider an appropriate strategy for promoting SMBG adherence. Addressing low 
compliance with SMBG may promote positive social change through improved T2DM 
management, self-care, adherence to daily SMBG and treatment, and improved patient 
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Section 1: Introduction 
Introduction 
Scott (2014) estimated that 382 million people were affected by diabetes mellitus 
(DM) in 2013 and predicted a 55 % increase in affected individuals by 2035. Diabetes 
mellitus is the seventh leading cause of death in the United States (Loucks et al., 2016). 
Approximately 4 million deaths were attributed in 2010 from complication of DM such 
as myocardial infarction, stroke, kidney failure, blindness, and lower limb amputations 
(Scott, 2014). 
The prevalence of Type 2 diabetes mellitus is on rise in the United States and 
affects minority ethnic and racial group disproportionally (Chow et al., 2012). Despite 
improvement of access to medical care, African Americans and Hispanic Americans have 
a higher prevalence and complication from DM compared with White Americans (Chow 
et al., 2012). For instance, 18.7% of all African Americans and 11.8% of Hispanic 
Americans aged 20 years and older have been diagnosed with diabetes compared with 
7.1% of non-Hispanic White Americans. On the other hand, the risk of diabetes is 77% 
higher among African Americans, and 66% higher among Hispanic Americans than 
among non-Hispanic white Americans (Chow et al., 2012). 
Blood glucose monitoring is the ongoing measurement of the level of the 
concentration of glucose in the blood to maintain consistent glucose levels, and home 
glucose monitoring is referred as self-monitoring of blood glucose (SMBG) (Whitmore, 
2012). SMBG is one of the most important skills in diabetes self-management and 
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understanding and addressing barriers that prevent patients with T2DM to comply with 
SMBG may improve the patient adherence to SMBG. 
Problem Statement 
The practice setting identified for this project was a primary care practice clinic 
located in a large urban city in the southern United States. The clinic primarily serves 
African Americans and Hispanic Americans.  One in two patients registered in the clinic 
had an active diagnosis of T2DM, and more than 60% of patients with T2DM had both 
hypertension and diabetes (Personal Communication, 2017). One in three patients with 
T2DM were treated with hypoglycemic drugs and insulin, and, as a result, they were 
required to monitor their blood glucose before self-injecting insulin. Seventy-five percent 
of the blood glucose logs given to patients to record their blood glucose were not filled 
out completely during their monthly follow-up appointment (Personal Communication, 
2017). As a result, for effective management of the patient’s medical condition, the 
providers at the clinic wanted to know the reason for their patients’ low compliance to 
SMBG. 
Osborn, Cavanaugh, Wallston, and Rothman (2010) stated that interventions to 
promote self-care activities such as blood glucose self-monitoring can control the level of 
hemoglobin A1C. Loucks et al. (2016) suggested that patients should be educated toward 
behaviors that improve glycemic control such as blood glucose monitoring. Patients with 
T2DM are advised to monitor their blood glucose closely to avoid complications that can 
occur when blood glucose levels rise and damage the small nerves and blood vessels in 
the body. By controlling blood glucose, patients may reduce the risk of microvascular 
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and neurovascular complications that kill one individual with DM every 6 seconds 
(Yuncken, 2014). Although the diabetes management program at the practice site exist to 
help patients with T2DM monitor and control their blood sugar level on a day-to-day 
basis, many patients still do not monitor their blood glucose regular and as a result do not 
have adequate blood glucose control.  
 A lack of knowledge often drives patient preferences for certain diabetes 
management programs compared with others (Lopez et al., 2016). As a result, a clear 
understanding of patient preferences, needs, and values could facilitate the design of 
better patient-centered disease management programs that may result in improved patient 
participation, engagement, adherence, health outcomes, and quality of life (Lopez et al., 
2016) 
Purpose 
Health care providers at the practice site educated patients with T2DM to check 
their blood glucose often and record the glucose meter reading in a blood glucose log.  
Follow-up visits were scheduled every 3 months. However, during the follow-up visit, 
the blood glucose logs given to patients to record their blood glucose level were not 
completed. As a result of the poor compliance to SMBG, the health care providers were 
relied solely on the value of the hemoglobin A1C drawn every 3 months, to adjust 
medications for patients on insulin therapy. At this time, the hemoglobin A1C (HbA1C) is 
considered to be the most relevant physiologic outcome target of uncontrolled glycemia , 
because it indicates overall glucose control, and it is a proven risk predictor for diabetic 
microvascular complications (Nyomba et al., 2014). On the other hand, SMBG is 
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considered to be one of the most important skills in diabetes self-management and is the 
only method currently available that allows adjustments in insulin dosage during meal 
time and hours of sleep to control and adjust insulin or oral hypoglycemic medications, as 
well as to prevent impending hyperglycemic or hypoglycemic emergencies (Nyomba et 
al., 2014). Therefore, it was important that patients understood the value of SMBG and 
that providers understood the barriers that prevent patients from self-monitoring and 
recording their glucose levels in the home setting. As a result, the project question was: 
What barriers prevent patients with T2DM from self-monitoring their blood glucose as 
prescribed? The answer to this question may have addressed the gap in practice which 
was the lack of providers’ knowledge about the raison that prevent patients with T2DM 
to SMBG  
The purpose of this project was to examine barriers that prevent patients with 
T2DM from self-monitoring their blood glucose as prescribed and then to educate 
providers on strategies to improve patient monitoring. Addressing barriers to SMBG may 
help to achieve the following: (a) promote self-care, (b) improve patient adherence to 
SMBG and treatment, (c) improve the use and recording of blood glucose in logs 
provided by health care provider, (d) early detection of complications associated with 
uncontrolled hyper or hypo glycemia, (e) reduce financial cost associated with 
complications of diabetes, and (f) improve patient’s quality of life. 
Nature of the Doctoral Project  
The nature of this quality improvement doctoral project was to identify barriers to 
SMBG and search for the best available evidence to overcome those barriers and to use 
5 
 
the knowledge gained to provide health care providers with strategies to improve patient 
compliance to SMBG. I searched the Walden University library databases CINAHL Plus 
with full text, PubMed, CINAHL & MEDLINE, and ProQuest for literature that explores 
barriers or problems related to patients with T2DM to SMBG. Literature of interest were 
peer-reviewed articles published between 2010 and 2017 using the Boolean operator 
AND with the following identified concepts: hyperglycemia, SMBG, blood glucose self-
monitor, fear, glycemic control, diabetes mellitus, blood glucose, blood sugar, barriers, 
self-testing, patient education, and health belief model. 
The clinic providers have documented barriers described by the patients on a 
separate form within the chart with no identifying data as part of a quality improvement 
project at the clinic from July 01, 2017, to September 30, 2017. I completed analysis of 
the retrospective deidentified data documented the practice of SMBG and patients’ 
barriers to compliance for common themes similar to a qualitative method describing 
barriers to SMBG. Next, I identified barriers and used those barriers to conduct a 
literature review as a second level of evidence. I used key words from the types of 
barriers identified in the analysis of the deidentified chart data to identify published 
strategies for promoting SMBG. I provided a report containing the strategy for 
overcoming each barrier identified to the clinic medical director. 
Whitmore (2012) suggested that SMBG is only useful when patients understand 
how, when, where, and why to test and what to do with the result, and on the other hand, 
providers will rely on the value of the HbA1C taken every 3 months to adjust their 
treatment. HbA1C, as compared to SMBG, does not provide a clear picture of the patient 
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glucose level during fast and preprandial and postprandial time, which can trigger an 
adjustment in the patient’s daily medication dose and frequency as well as lifestyle 
change. 
Significance 
T2DM affects disproportionally low-income groups, and program designed at 
reducing T2DM inequalities cost millions of tax payers’ dollars each year (Chaufan, 
Constantino, & Davis, 2013). The outcome of this DNP project may help local 
stakeholders, community leaders, providers, nurses, dieticians, and health care policy 
makers to invest in a low cost-efficiency program aimed in reducing barriers to SMBG. 
Socioeconomic differences have been linked in disease and death rated difference in time 
from infectious diseases in the 18th and 19th centuries due to lack of sanitation, then to 
diseases of malnutrition due to insufficient calories, and this century to diseases of excess 
calories (Chaufan et al., 2013). T2DM, a metabolic disease, can be linked to the disease 
of excess calories consummation.  
SMBG can help patients, family, and health care providers understanding what 
foods produce an abnormal increase in blood glucose during preprandial and postprandial 
time and adjust their diet accordingly. SMBG will provide patients as well as health care 
providers the opportunity to link the value of their blood sugar with the consummation of 
certain high calories with less nutritional value foods. Bodenheim and Grumbach (2016) 
pointed out that the food industry spends billions of dollars to advertise for foods, which 
most have poor nutritional value. The findings of this project will support improvement 
of the clinic providers’ ability to address barriers that prevent patients to adhere to 
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recommended SMBG. As a result the clinic providers will empower patients by 
educating them on how, when, where, and why to test and what to do with the result in 
order to improve the patient self-care efficacy, self-confidence, quality of life, and a 
positive social change. 
Summary 
Many diabetes management programs exist to help patients with T2DM monitor 
and control their blood sugar level on a day-to-day basis and improve their health 
outcomes; however, a lack of knowledge exists about what drives patient preferences for 
certain diabetes management programs compared with others (Lopez et al., 2016).  As a 
result, a clear understanding of patient preferences, needs, and values as related to SMBG 
could facilitate the design of better patient-centered disease management programs that 
may result in improved patient participation, engagement, adherence, health outcome, 
and positive social change (Lopez et al., 2016). 
In Section 1, I presented the problem statement, the purpose, the nature of this 
doctoral project, and it significance, whereas in Section 2, I will develop the concepts, 




Section 2: Background and Context 
Introduction 
A primary care practice clinic located in a large urban city in the southern United 
States that primarily serves African American and Hispanic Americans reported that one 
in two patients registered in the clinic had an active diagnosis of T2DM, and more than 
60% of patients with T2DM had both hypertension and diabetes (personal 
communication, 2017).  One in three patients with T2DM were treated with 
hypoglycemic drugs and insulin, and, as a result, they were required to monitor their 
blood glucose before self-injecting insulin. Seventy-five percent of the blood glucose logs 
given to patients to record their blood glucose were not accurately completed during their 
monthly follow-up appointment. As a result, the project sought to determine what barriers 
prevent patients with T2DM to SMBG daily. In Section 2, I will develop the concepts, 
models, theoretical framework, the relevance to nursing practice, and my role as the DNP 
student. 
Concepts, Models, and Theories 
In this project, I examined barriers that prevent patients with T2DM to self-
monitor blood glucose daily using the health belief model (HBM) theory. HBM assumes 
that people fear disease, and that health actions are motivated by the degree of fear and 
the benefits obtained (McEwin & Wills, 2014). HBM has six constructs: 
1. The first construct is perceived susceptibility which is the patient’s opinion of 
chance of getting the disease (McEwin & Wills, 2014). Sharma (2011) 
estimated that people perception of getting any harmful condition vary from 
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deny to fear of acquiring the disease, and the likelihood of following 
preventive health behavior is associated to the degree of fear the person feels.  
2. The second construct of HBM is perceived severity, which is the patient’s 
opinion of how serious a condition and its sequelae are (McEwin & Wills, 
2014). People have different perception of the extent of harm that can be 
caused by a disease. Some patients may be concerned by the medical aspect of 
the disease such as sign and symptoms, temporary limitation, permanent 
limitation, and death whereas other patients have a broader view such as the 
disease’s outcomes on their family, job, and relationships (Sharma 2011) 
3. The third construct of the HBM is perceived benefits, which is the patient’s 
opinion on the efficacy of the advised action to reduce risk (McEwin & Wills, 
2014) Sharma (2011) suggested that when patients known that there are 
available effective alternatives susceptible to reduce the severity of the 
condition, they are more likely to take action. 
4. The fourth construct is perceived barriers, which is the patient’s opinion of the 
tangible and psychological cost of the advised action (McEwin & Wills, 
2014). The patient may consider the advised action to be expensive, 
inconvenient, unpleasant, painful, or upsetting to execute (Sharma 2011) 
5. The fifth construct of the HBM is cues to action which are the diverse actions 
that will activate the readiness to act and stimulate other behaviors (McEwin 
& Wills, 2014). Sharma (2011) suggested that theses precipitation forces that 
push the patient to take action may be internal such as a perception of a bodily 
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state or external such as media, follow-up postcard from the doctor office, or 
interpersonal interactions 
6. The sixth and final construct of the HBM is self-efficacy, which is the 
patient’s confidence in the ability to successfully perform an action (McEwin 
& Wills, 2014). Sharma (2011) added that the action should be a specific and 
present behavior not a past or future one. 
A schematic representation of the HBM from Sanders et al. (2013) study is shown 
in Figure 1: 
 
I used the perceived barriers of the HBM to help identify perceived barriers that 
prevent patients with T2DM to SMBG daily, and to propose interventions that may help 
improve compliance. The perceived barriers of HBM, which is the patient’s opinion of 
the tangible and psychological cost of the advised action to SMBG (McEwin & Wills, 
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2014), resulted in identified barriers that prevent patient from adhering to the advised 
action of SMBG such as expensive, inconvenient, unpleasant, painful, or upsetting to 
execute (Sharma 2011) 
 Gucciardi et al. (2013) used the HBM in a semistructured interviews involving 12 
participants from a community health center in Ontario, Canada, to examine the views 
and current practice of SMBG among Black Caribbean and South Asian individual with 
noninsulin-treated T2DM. Gucciardi et al. (2013) used HBM to explain and predict 
health behavior, assuming that patients will take recommended health-related action if 
they feel that they can successfully perform the action (self-efficacy), or they can avoid 
negative health condition by doing so (perceived severity). 
Aghamolaei, Tavafian, and Madani (2011) used both HBM and the theory of 
planned behavior (TPB) to examine low adherence to helmet use among Iranian 
motorcycle drivers despite evidence that helmets use significantly reduced the likelihood 
of head and neck injuries during an accident. Aghamolaei et al. (2011) developed a self-
administered questionnaire based on TPB and HBM six constructs and found that 
motorcycle drivers who perceived a high level of behavioral control, intention to use a 
motorcycle helmet, few barriers, high self-efficacy, and a high number of cues to action 
were the most likely to use a motorcycle helmet study.  
Sanders et al. (2013) used the HBM to assess patients’ low compliance with 
hearing aid despite evidence that suggests that hearing aids are effective treatment for 
patients with hearing deficit. Sanders et al. (2013) develop a hearing belief questionnaire 
(HBQ) based on the six constructs of HBM, and found that despite the fact that many 
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factors in common influence health behavior, HBM was an appropriate framework for 
examining and predicting hearing health behavior  
Shojaei et al. (2016) used the HBM to assess the effects of the HBM-based 
educational program on the nutritional knowledge and behavior of CABG patient found 
that nutrition education based on HBM seems to be effective in improving nutritional 
knowledge, dietary behavior, perceived severity, and perceived benefit and barriers. 
Relevance to Nursing Practice 
Cost as Barriers to SMBG 
Gucciardi et al. (2013) used the HBM to examine the views and current practice 
of SMBG among Black Caribbean and South Asian individual with noninsulin-treated 
T2DM. Gucciardi et al. (2013) used a thematic network analysis of NVivo 8 to analyze 
the different constructs of HBM as related to SMBG. This qualitative study revealed 
patients’ acknowledgement of the benefit of SMBG and pointed out the cost of glucose 
meter and test strip as a main barrier to SMBG (Gucciardi et al., 2013). This research 
opens the door to further research on SMBG for noninsulin-treated patients while 
advising providers to consider patients clinical, financial, and social support before 
ordering the use and frequency of SMBG 
Elgart, González, Prestes, Rucci, and Gagliardino (2016) used an observational 
retrospective study of 657 patients for more than 12 months to evaluate de frequency of 
SMBG and attainment of HbA1c target values. Drugs and test strip used for 12 months 
and the different laboratory test results were analyzed. The study revealed a correlation 
between the increase in use and frequency of SMBG and the cost of test strip that 
13 
 
represented 50% of the total cost of the diabetes program with an attainment on HbA1c 
target value, and patient self-management and empowerment (Elgart et al, 2016).  
Patients’ Emotion as Barriers to SMBG 
Mehmet, Hussey, and Ibrahim (2015) conducted an interview of 76 randomly 
selected patient from the outpatient clinic of the Queen Mary’s Hospital diabetes center, 
in the United Kingdom, to analyze their perceptions of injecting insulin and SMBG in the 
presence of others. Two main questions were asked about patients’ level of comfort in 
self-injection insulin and self-monitoring blood glucose on front of others, and the 
feelings associated of doing so. A thematic analysis of the questionnaire revealed that 
patients across all ages, gender report problems with injecting insulin and SMBG in 
public and the work place. The study suggested that the heath care provider should 
identify patients psychological needs and emotional needs, and address them adequately 
in order to limit or avoid that patients develop a psychological resistance to insulin and 
SMBG (Metmet et al, 2015). 
Lack of Diabetes Education  
To determine where an association exists between diabetic education and 
improvement in glycemic control for patients newly diagnosed with DM, Weaver et al. 
(2014) used a retrospective cohort study of 16,410 adults aged 18 years and older 
residing in the Calgary Zone of Alberta Health Service in Canada from October 2005 to 
June 2008. Change in HbA1C during a period of 6 to 18 months of patients who attended 
the Diabetes Essentials program within the first 6 months after diagnosis with those who 
did not attend was compared (Weaver et al., 2014). Diabetes Essential program is a free, 
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publicly funded introductory diabetes education that targets people newly diagnosed with 
DM. Weaver et al. (2014) used propensity score matching of Stata MP to examine the 
interaction between baseline HbA1c and Diabetes Essentials participation. The study 
found that a brief introductory didactic diabetes education program among newly 
diagnosed diabetes was associated with a reduction in HbA1c (Weaver et al., 2014). This 
study implies that a low-cost diabetes education program should be a part of any 
interventions plan of care of for patients newly diagnosed with T2DM to achieve a better 
glycemic control.  
In a study to identify strategies to improve self-care management among low-
income and minority group diagnosed with T2DM, Akohoue et al. (2015) used a mixed-
method design with seven focus group discussion and written questionnaires to assess 17 
adults patients aged 21 years and older with T2DM recruited from the Family Medicine 
Clinic (FMC) in Nashville, Tennessee, five caregivers of patients with T2DM, 14 
physicians, and one nurse practitioner.  At the conclusion of the study, Akohoue et al. 
(2015) found that diabetes education at the clinic was the most common agreed upon 
strategy among patients/caregivers and providers, and as a result suggest to improve 
patient-provider communication in discussing treatment goals and strategies 
Edwards (2013) developed a quality innovation productivity and prevention 
(QIPP) model in United Kingdom to enhance engagement and education around SMBG 
in order to achieve glycemic control while controlling the cost associated to SMBG. A 
total of 1,187 patient with T2DM were identified and 718 patients participated in the 10-
minutes consultation and education on SMBG guidelines. The new model was 
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successfully implemented by providers and patients with T2DM and resulted in better use 
and quality of SMBG, and cost saving. Edwards (2013) suggested that primary care 
provider should provide clear education and empower patients with diabetes to interpret 
their blood glucose reading  
Johnson et al. (2014) conducted a retrospective pre-post analysis study at Balls 
Food Stores in Kansas City, to elicit the effects of a pharmacist-led diabetes self-
management program on three key metabolic parameters such as glycosylated 
hemoglobin (HbA1c), low-density lipoprotein cholesterol (LDL-C), and mean arterial 
blood pressure (MAP) among patients diagnosed with DM. Johnson et al. (2014) 
analyzed 65 eligible company employees and their dependents aged 18 years and older 
with a diagnosis of Type 1 or Type 2 diabetes from medical claims data between 
November 2008 and December 2012 among 183 patients who participated in the 
program. The program consisted of one-on-one 30 minutes of diabetic education related 
to healthy lifestyle, medication adherence, and blood glucose self-monitoring with the 
clinical pharmacists for an average of six visit during the year, and during each visit, the 
patient blood pressure, blood sugar, and weight were collected (Johnson et al , 2014). A 
statistical analyze of the three key metabolic parameters such as HbA1C, LDL-c, and 
MAP from baseline to one year were statistically significant, and the glycemic control 
was achieved (Johnson et al, 2014). A close collaboration between providers and clinical 
pharmacists about key metabolic parameters of patients with T2DM can improve diabetes 
education and patient adherence to glycemic control. 
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Lack of Social Support as Barriers to SMBG  
Costa, Pereira, and Pedras (2012) conducted a study of 179 patients with T2DM 
selected from several health centers in the North of Portugal, using a multidimensional 
diabetes questionnaires, revised summary of diabetes self-care activities scales, and 
planned behavior questionnaire to assess partner support, social-cognitive variables and 
their role in adherence to SMGB. Pearson’s correlation coefficient was used to analyze 
relationship among social-cognitive variables, spousal support and adherence, a multiple 
regression analysis was conducted to assess the best predictors of adherence. The study 
revealed a positive relationship among social-cognitive variables, spousal support, and 
adherence to SMBG and glycemic control. Partner support shows to be determinant in 
diabetes self-care, and as a result, health care providers should include partners in 
patients’ plan of care (Costa et al, 2012)   
The literature revealed cost, patients ’emotions, lack of social support, and lack of 
diabetes education as barriers to SMBG. 
Previously Used Strategies and Standard Practice. 
Meetoo, McAllister, and West (2011) suggested that SMBG provide a very 
helpful complement to HbA1c, because it can reveal which aspects of glycemic control 
are most problematic between the fasting, preprandial or postprandial, and signaling the 
need to change or adjust therapy to improve glycemic control. Holt (2014) suggested that 
the frequency of SMBG should be prescribed on an individual basis, but it is only by 
monitoring blood glucose level on a regular basic that patterns and trends in glycemic 
control  can be identified  and treated. Whitmore (2012) suggested that SMBG is an 
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important and effective tool in the management of diabetes, and it is only useful only 
when the result of monitoring are acted upon by educating patient on how, when, where, 
and why to test and what to do with the result 
 Local Background and Context 
The practice setting for this project was a primary care practice clinic located in a 
large urban city in the southern United States that primarily serves African American and 
Hispanic Americans. One in two patients registered in the clinic had an active diagnosis 
of T2DM. One in three patients with T2DM was treated with hypoglycemic drugs and 
insulin, and as a result, they were required to monitor their blood glucose before self-
injecting insulin. Seventy-five percent of the blood glucose logs given to patients to 
record their blood glucose were not filed completely during their monthly follow-up 
appointment. As a result, the provider relied solely on the value of the HbA1c drawn 
every 3 months, for patients on insulin therapy, to adjust their medications. The purpose 
of the project was to examine barriers that prevent patients with T2DM to SMBG daily. 
Definitions of Terms  
Chronic disease: A disease state that is long lasting or recurrent (Medlineplus, 
2016). 
Clinical practice guidelines: A set of recommendations made by recognized 
authorities regarding the screening, diagnosis, treatment, and management of specific 
conditions (White & Dudley-Brown, 2012).  




Diabetic nephropathy: A kidney disease or kidney damage often occurs through 
time in people with diabetes (Medlineplus, 2016). 
Diabetic peripheral neuropathy: A nerve damage that occurs in people with 
diabetes by decreased blood flow and a high blood sugar level (Medlineplus, 2016). 
Glucose: A sugar that comes from the foods that one eats (Medlineplus, 2016). 
Glycosylate hemoglobin (A1C): A lab test that shows the average level of blood 
sugar (glucose) over the previous 3 months (Medlineplus, 2016). 
Health literacy: Health literacy is defined as the degree to which individuals have 
the capacity to obtain, process, and understand basic health information and services 
needed to make appropriate health decisions (AHRQ, 2010). 
Insulin: A hormone that helps the glucose get into your cells to give them energy 
(Medlineplus, 2016). 
Metabolic syndrome: A group of condition such as high blood pressure, high 
blood sugar, high level of triglycerides that puts an individual at risk for heart disease and 
diabetes (Medlineplus, 2016). 
Self-monitor blood glucose (SMBG): A glucose monitoring at home (Whitmore, 
2012. 
The prevalence of T2DM is on rise in the United States and affects minority 
ethnic and racial group disproportionally (Chow et al., 2012). Despite improvement of 
access to medical care, African American and Hispanic American have a higher 
prevalence and complication from DM compared with Whites. For instance, 18.7% of all 
African American and 11.8% of Hispanic American aged 20 years and older have been 
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diagnosed with diabetes compared with 7.1% of non-Hispanic White Americans. On the 
other hand, the risk of diabetes is 77% higher among African Americans, and 66% higher 
among Hispanic Americans than among non-Hispanic white Americans (Chow et al., 
2012).  
Role of the DNP Student 
.  Patients with T2DM at the clinic where this project took place were not compliant 
with SMBG during their follow-up appointment. Patients with T2DM on insulin therapy 
were required to monitor their blood glucose before self-injecting insulin. Three in four 
of the blood glucose logs given to patients to record their blood glucose were not filled 
completely during their monthly follow-up appointment. I contacted the clinic physician 
to discuss the issue and we decided as part of a quality improvement project at the clinic 
to document the reason that prevents patients from SMBG. This documentation began in 
July 2017 and is a routine part of the clinic visit with patients with T2DM.  
As a result, the clinic providers documented patient compliance with daily SMBG 
at each patient visit. The providers also documented barriers to any noncompliance of 
SMBG. This information was maintained on a separate form with no identifying data 
within the patient chart and was provided to me for review after IRB approval was 
obtained. I reviewed the data and summarized the percentage of patients who were 
noncompliant as well as identified themes related to barriers to daily self-monitoring. 
Summary 
The literature review reveals that multiple barriers exist to SMBG present in all 
socioeconomic, age group, gender, and ethnic racial group of patients with T2DM. The 
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literature identifies cost, patients’ emotions, lack of social support, and lack of diabetes 




Section 3: Collection and Analysis of Evidence 
 Introduction 
The prevalence of T2DM is on rise in the United States and affects minority 
ethnic and racial group disproportionally. Despite improvement of access to medical care, 
African American and Hispanic American have a higher prevalence and complication 
from DM compared with Whites (Chow et al., 2012). SMBG is considered to be one of 
the most important skills in diabetes self-management and is the only method currently 
available that allows adjustments in insulin dosage during meal time and hours of sleep to 
control and adjust insulin or oral hypoglycemic medications, as well as to prevent 
impending hyperglycemic or hypoglycemic emergencies (Nyomba et al., 2014). The 
purpose of this project was to explore barriers to noncompliance with SMBG at a primary 
care clinic and make recommendations to improve compliance.  
The literature review revealed multiple barriers to SMBG related to cost, patients’ 
emotions, lack of diabetes education, and lack of social support. It was not known which 
barriers were common at the practice site and, therefore, I identified those barriers and 
then searched the literature to identify strategies for overcoming similar barriers.  A 
report containing the strategy for overcoming each barrier identified was provided to the 
clinic medical director. In Section 3, I will restate the practice focus question, identify the 
source of evidence used to address the problem of low compliance to daily SMBG, and 




The practice setting for this project was a primary care practice clinic located in a 
large urban city in the southern United States that primarily serves African American and 
Hispanic Americans. At the clinic one in two patients had an active diagnosis of T2DM, 
and more than 60% of patients with T2DM had both hypertension and diabetes. One in 
three patients with T2DM was treated with hypoglycemic drugs and insulin, and as a 
result, they were required to monitor their blood glucose before self-injecting insulin. 
Seventy-five percent of the blood glucose logs given to patients to record their blood 
glucose were not filed completely during their monthly follow up appointment. As a 
result, for an effective management of the patient’s medical condition, the providers at 
the clinic wanted to know the reason of low compliance to SMBG. 
In this project, my purpose was to explore barriers that prevent patients to comply 
with the recommended daily SMBG and to make recommendations to the providers on 
how to improve compliance. The project question was: What barriers prevent patients 
with T2DM to SMBG daily?  
Sources of Evidence 
Upon approval from Walden IRB, I obtained a letter of cooperation and approval 
from the clinic medical director to give me the deidentified data from the patients’ chart 
that contain their narrative of SMBG compliance that was previously obtained by the 
clinic providers as part of a quality improvement project at the clinic. I read the patient’s 
narrative looking for repeated ideas or patterns of thought using concepts from the fourth 
construct of HBM, the perceived barriers and the review of literature to classify the 
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information for common themes describing barriers to SMBG daily and make 
recommendations based on current evidence on how to improve compliance. A second 
level of evidence came from a literature review after the barriers were identified. I used 
key words from the barriers to identify published strategies for promoting SMBG given 
the types of barriers identified in the analysis of the deidentified chart data. 
Participants 
The providers in the clinic had interviewed and documented the patients’ 
responses on a separate form with no identifying data within the patient chart during their 
routine follow-up appointment, consistent with the quality improvement project for the 
clinic that started in July 2017. To reach data saturation and gain insight into low 
compliance to SMBG while taking into consideration the number of patients diagnosed 
with T2DM, the clinic medical director provided me with the deidentified data from 
twenty four patients ‘charts randomly chosen to provide for data saturation with an 
identification code from P1 to P24. The retrospective deidentified data documented the 
practice of SMBG and patients’ barriers to compliance from July 01, 2017. to September 
30, 2017. Five patients who answered positively that they performed SMBG daily were 
excluded, and 19 patients’ questionnaires were given a new identification code from P1 
to P19. 
After barriers were identified, a report containing the strategy for overcoming 




As a part of a quality improvement project at the clinic, and during each 
encounter with a patient diagnosed with T2DM, and on insulin therapy, the clinic 
providers had documented the response to the following three questions only on a 
separate form within the chart with no identifying data. Those three questions were 
selected among the questions that are routinely asked during follow-up visit about the 
patient daily SMBG compliance, “Do you check your blood sugar every day? If no, how 
often do you check your blood sugar? And tell us what prevents you from checking your 
blood sugar every day?” Upon approval from Walden IRB, a letter of cooperation and 
approval was obtained from the clinic to get access to the deidentified patients’ narrative 
of their SMBG behavior. A reading of the patients’ narrative of the reason that prevent 
them to SMBG daily allowed me to identify repeated ideas or patterns of thought using 
concepts from the fourth construct of HBM the perceived barriers, which is the patient’s 
opinion of the tangible and psychological cost of the advised action (McEwin & Wills, 
2014), and can be expensive, inconvenient, unpleasant, painful, or upsetting to execute 
(Sharma, 2011). I reviewed each deidentified data and grouped them according to the 
themes related to barriers to daily self-monitoring revealed by the review of literature and 
the HBM. I also summarized the percentage of patients who are noncompliant. For 
instance, the literature review revealed that there are multiple barriers to SMBG related to 
cost, patients’ emotions, lack of diabetes education, and lack of social support. This 
thematic analysis allowed me to identify similar and/or different patterns and themes 
from the review of literature and make recommendations based on current evidence on 
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how to improve compliance to SMBG at the clinic. The retrospective deidentified data 
documented the practice of SMBG and patients’ barriers to compliance from July 1, 2017 
to September 30, 2017.  
After obtaining the information about the barriers that the patients present for low 
compliance to SMBG, a report containing the strategy for overcoming each barrier 
identified was provided to the clinic medical director.  
Protection 
The clinic providers used a form documenting SMBG practices and barriers to 
compliance with providers’ recommendations. The providers documented barriers 
described by the patients on a separate form within the chart with no identifying data to 
insure data security and anonymity as a part of a quality improvement project at the 
clinic. The clinic provided a letter of cooperation and approval. Upon approval from 
Walden IRB the forms completed by the clinic providers from the quality improvement 
project were provided to me with a clinic identification number from Patient 1 (P1) to 
Patient 24 (P24). Five patients who answered positively that they performed SMBG daily 
were excluded, and 19 patients’ questionnaires were given a new identification code from 
P1 to P19 
Analysis and Synthesis  
A reading of each patient with T2DM narrative of the reason that prevented them 
from SMBG daily, previously obtained during their routine follow-up visit with the clinic 
providers, allowed me to identify repeated ideas or patterns of thought using a thematic 
coding, concepts from the HBM, and the review of literature. I read each deidentified 
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data and group them according to the themes related to barriers to daily self-monitoring 
revealed by the review of literature and the HBM. I reported the findings by listing all 
types of barriers that were identified using thematic coding and the frequency of their 
occurrence as well as the percentage of patients who were noncompliant. I provided a 
report for the clinic medical director that identified strategies to overcome identified 
barriers. For instance, the literature review revealed that there are multiple barriers to 
SMBG related to cost, patients’ emotions, lack of diabetes education, and lack of social 
support. This retrospective thematic analysis of patients’ narrative allowed me to identify 
patterns and themes that prevent them to SMBG daily. The retrospective deidentified data 
documented the practice of SMBG and patients’ barriers to compliance from July 01, 
2017, to September 30, 2017. The results of this project are specific to the setting where 
the project took place and because of the small sample size and the open ended questions, 
the results cannot be transferred to other settings.  
Summary 
The literature review revealed that there are multiple barriers to SMBG present in 
all socioeconomic, age group, gender, and ethnic racial groups of patients with T2DM 
The literature revealed cost, patients’ emotion, lack of social support, and lack of diabetic 
education as deterrents to daily SMBG. In the next section of this project, I will report the 
findings that resulted from analysis and synthesis of the collected data and the identify 
recommended solutions to improve SMBG compliance  
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Section 4: Findings and Recommendations 
Introduction  
The practice setting for this project was a primary care practice clinic located in a 
large urban city in the southern United States that primarily serves African Americans 
and Hispanic Americans.  One in three patients with T2DM was treated with 
hypoglycemic drugs and insulin, and, as a result, they were required to SMBG before 
self-injecting insulin. Of the blood glucose logs given to patients to record their blood 
glucose, 75% were not filled out completely during their monthly follow-up appointment 
(Personal Communication, 2017). As a result, for medical management of the patient’s 
condition, the providers relied solely on the value of the HbA1C drawn every 3 months.  
SMBG is one of the most important skills in diabetes self-management and is the 
only method currently available that allows adjustments in insulin dosage during meal 
time and hours of sleep to control and adjust insulin or oral hypoglycemic medications, as 
well as to prevent impending hyperglycemic or hypoglycemic emergencies (Nyomba et 
al., 2014). For an effective management of the patient’s medical condition, the providers 
at the clinic wanted to know the reason for low compliance to SMBG as part of the 
implementation of the quality improvement project. The project question to address the 
gap in practice was: What barriers prevent patients with T2DM from daily SMBG as 
prescribed? In this project, my purpose was to identify barriers that prevent patients from 
complying with the recommended daily SMBG and to provide the clinic with a report 
containing strategies to overcome those barriers. 
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Upon receipt of Walden IRB approval number 04-26-18-0375805, I received a 
letter of cooperation and approval from the clinic medical director who gave me the 
deidentified data from patients’ chart. The data included the narrative of SMBG 
compliance previously obtained by the clinic providers as part of a quality improvement 
project at the clinic between July 01, 2017, and September 30, 2017. I received 24 
responses of patient’s narrative with a clinic identification number form patient number 
one (P1) to patient number 24 (P24).  Five patients who answered positively that they 
performed SMBG daily were excluded, and 19 questionnaires were attributed a new 
identification number from P1 to P19. I identified themes that prevents patients from 
SMBG daily based on the theory of the HBM by completing thematic coding using 
Microsoft word Comments and Macros. 
Findings and Implications 
Data Analysis 
I completed thematic coding by conducting a constant comparison across each 
response on the questionnaires, and each response was edited with Microsoft Word 
(Table 1). I familiarized myself with the data by reading the transcripts of the 19 patient 
responses to the third question of the clinic quality improvement project questionnaire  
repeatedly to identify key ideas and recurrent themes that were highlighted and coded 
using Microsoft Word Comments. The analysis focused solely on areas deemed relevant 
to the project question and the codes identified were consistent with those reported in the 
literature found in previous research. The codes were: cost of health care, lack of diabetes 
education, testing frequently evokes an emotional response, and lack of social support. 
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After the themes and codes were identified, the next step was to extract only those themes 
and codes to a new document using Microsoft Word Macros. The Macro program used 
was created by Fredborg (2013), and it extracted the data into a new Microsoft Word 
table with five columns. For each Comment (code), the table showed the page number, 
the text that was highlighted and commented (scope), the comment itself, the name of the 
author who inserted the comment and the date when the comment was added (Fredborg, 
2013). I modified the original version to have a six-column table which included the 
patient identification code. The thematic coding and analysis of the 19 responses using 
Microsoft Word Macros revealed 24 codes that were transferred to Microsoft Excel to 
arrange the codes in alphabetic order. The last step was to select only the three columns 
of the table that were relevant to the data analysis, and to replace their original name in 
the macro program by an explicit denomination. For instance, Column B (line) was 
replaced by patient ID number, Column C (comment scope) was replaced by patient’s 
response to questionnaire, and Column D (comment text) was replaced by thematic 









1 The pain is too much. 
2 My work schedule and I cannot check it at work. 
3 No meter or test strip. 
4 Work. 
5 Just the inconvenience of it. I feel it is a waste of time 
Especially if I’m in a rush in the morning. It takes up too much time. 
 
6 I can feel when my blood sugar is high or low then I check. 
7 It is embarrassing. I don’t want people to know I’m diabetic. 
8 It has been good number. When it is higher I check more often, until 
lower again. 
9 Forget. 
10 I’m afraid of the result. 
11 My numbers have been good. 
12 I don’t feel it is helping, my blood sugar will always rise after meal. 
13 I don’t know what to do with the result. 
14 Sometimes I’m just lazy to do it. 
15 Needle stick is painful. 
16 It hurt when I checked. 
17 My diabetes is not too serious. 
18 I don’t just understand why I need to check more often. 








Thematic Coding   
Patient 
ID number 
Patients’ responses to questionnaire Thematic coding 
19 I don’t have enough test strip, and it is 
expensive. 
Cost of self-care. 
3 No meter or test strip. Cost of self-care. 
6 I can feel when my blood sugar is high 
or low then I check. 
Lack of diabetes education. 
11 My numbers have been good. Lack of diabetes education. 
12 I don’t feel it is helping, my blood sugar 
will always rise after meal. 
Lack of diabetes education. 
13 I don’t know what to do with the result. Lack of diabetes education. 
17 My diabetes is not too serious. Lack of diabetes education. 
18 I don’t just understand why I need to 
check more often. 
Lack of diabetes education. 
8 It has been good number. When it is 
higher I check more often, until lower 
again. 
Lack of diabetes education. 
7 I don’t want people to know that I’m 
diabetic. 
Lack of social support. 
9 Forget. Lack of social support. 
14 Sometimes I’m just lazy to do it. Lack of social support. 
7 It is embarrassing. Testing is embarrassing (emotion). 
5 Just the inconvenience of it. Testing is inconvenient (emotion). 
15 Needle stick is painful. Testing is painful (emotion). 
1 The pain is too much. Testing is painful (emotion). 
16 It hurts when I checked. Testing is painful (emotion). 
2 My work schedule. Testing is time conflicting (emotion). 
5 It takes up too much time. Testing is time consuming (emotion). 
5 I feel it is a waste of time 
Especially if I’m in a rush in the 
morning. 
Testing is time wasting (emotion). 
6 A waste of time. Testing is time-consuming (emotion). 
2 I cannot check it at work. Testing produces workplace conflict 
(emotion). 
4 Work. Testing produces workplace conflict 
(emotion). 






The 24 codes revealed that low adherence to SMBG was related to the cost of 
supplies. Three of the 24 codes revealed that low adherence to SMBG was related to the 
lack of social support. Seven of the twenty-four codes revealed that low adherence to 
SMBG was related to the lack of diabetes education. Twelve out of twenty-four codes 
revealed that low adherence to SMBG was related to patients’ emotions.  
Unanticipated Limitation 
Only two out of twenty-four codes revealed that low adherence to SMBG was 
related to the cost of supplies. It is possible that because only one response was coded, 
barriers to SMBG may have been under-reported. On the other hand, in my opinion 
barriers reported by patients with T2DM were likely to be those most important that 
prevent them to SMBG. 
Implication  
The findings suggested that patients’ financial, social support, emotional needs, 
and diabetes education may be important elements to consider before ordering the use 
and frequency of SMBG. Health care providers may find that including a partner in the 
patients’ plan of care, providing a clear diabetes education, and empowering the patient 
with T2DM to interpret their blood glucose reading may improve daily SMBG. 
Behavioral psychology predicts that negative experiences with SMBG prompt patients to 
avoid it as much as possible, and as a result for those who express fear of self-testing or 
fear of pain, the Diabetes Fear of Injecting and Self-testing Questionnaire (D-FISQ) can 
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be used to assess the level of anxiety and the need for psychotherapy (Snoek, Malanda, & 
Wit, 2008)  
Collaboration among the entire diabetes care community is needed to facilitate the 
design of better patient-centered disease management programs that will ensure that 
monitoring is performed and used to its fullest advantage which may result in improved 
patient participation, engagement, adherence, health outcomes, and quality of life. 
Recommendations 
The following recommendations were provided to the clinic medical director, 
after a careful analysis and synthesis of the literature for each identified barrier. Before 
ordering the use and frequency of SMBG, heath care provider may consider to identify 
patients ‘psychological and emotional needs, clinical, financial, and social support. For 
instance, Metmet et al. (2015) suggested that heath care provider could identify patients 
‘psychological needs and emotional needs and address them adequately in order to limit 
or avoid that patients develop a psychological resistance to insulin and SMBG while 
Gucciardi, et al. (2013) advised providers to consider patients clinical, financial, and 
social support before ordering the use and frequency of SMBG. 
Overcoming Cost of Self-Care   
Health care providers (HCP) should assess the patients’ clinical and financial 
needs before ordering the use and frequency of SMBG. Gucciardi, et al. (2013) advised 
providers to consider patients clinical, financial, and social support before ordering the 
use and frequency of SMBG. HCP should ensure that the glucose meters prescribed to 
patients with T2DM are compatible with the testing strips covered under the lowest tier 
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formulary of their health plans or encourage them to seek out glucose monitoring kits that 
use the lower cost testing strips. For instance, Gomes et al. (2010) suggested that even a 
modest change in the frequency of SMBG could lead to substantial cost reduction and 
unnecessary use of blood glucose test strips. Xie, Agiro, Bowman, and DeVries (2017) 
suggested that cost sharing that falls below 20% of testing strip costs can facilitate 
persistent self-monitoring, particularly among patients with poor glycemic control 
Overcoming Lack of Social Support 
HCP should include partners or family’s members in patients’ plan of care and 
refer patients to a diabetes support group. For instance, Costal et al. (2012) suggested that 
patients who perceive positive support from partners are more likely to develop an action 
and coping plan to overcome obstacles and constraints regarding SMBG. Lopez et al. 
(2016) suggested that patient with T2DM who are specifically referred to online or 
printed material by their HCP have a positive view and perception of HCP as being 
supportive and engaged, and therefore are more likely to share their hopes and goals, and 
to follow the recommended self-care behavior. Naderimagham et al. (2012) suggested 
that self-care behavior such as SMBG could not be achieved by patients with T2DM 
unless they received appropriate social support from HCP and families, and when 
patients received informational, emotional and instrumental support, they showed 
improved self-care behavior. Ong, Chua, and Ng (2014) suggested that HCP should 
encourage and facilitate support network to optimize SMBG use, and on the other hand, 




Overcoming Lack of Diabetes Education 
HCP should provide clear education and communication on the different purposes 
of SMBG, the treatment goals and strategies, and empower patients to interpret their 
blood glucose reading, and to recognize the symptom of abnormal glycemic. HCP should 
refer patients to a diabetes self- management education (DSME) program. For instance, 
Whitmore (2012) suggested that SMBG is an important and effective tool in the 
management of diabetes, and it is only useful when the result of monitoring is acted upon 
by educating patient on how, when, where, and why to test and what to do with the result. 
Akohoue et al. (2015) found that diabetes education at the clinic was the most common 
agreed upon strategy among patients/caregivers and providers, and as a result suggest to 
improve patient-provider communication in discussing treatment goals and strategies. 
Edwards (2013) suggested that primary care provider should provide clear education and 
empower patients with diabetes to interpret their blood glucose reading. Snoek et al. 
(2008) suggested that accurate symptom awareness and recognition when combined with 
experimentation can help reinforce the need to check BG levels. Stetson et al. (2011) 
suggested that SMGB is an integral element in diabetes self-management education and 
training (DSME/T) and have been successfully applied with good outcomes across 
multiple settings. Group diabetes education has been shown to increase adherence to 
SMBG and should be considered (Ong et al., 2014) 
Overcoming Patients’ Emotion  
HCP should remind patients that SMBG is a means to an end, not a goal in itself, 
avoid interpreting BG values as failures, be sensitive to the anxiety that surround SMBG 
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result, teach alternative site testing, and offer the Diabetes Fear of Injecting and Self-
testing Questionnaire (D-FISQ) for determining the level of anxiety and the need for 
psychotherapy. For instance, Snoek et al. (2008) suggest that teaching patients to avoid 
interpreting SMBG values as failures leads to a less negative opinion and more frequent 
testing, and for those who express fear of self-testing, offer them the Diabetes Fear of 
Injecting and Self-testing Questionnaire (D-FISQ) for determining the level of anxiety 
and the need for psychotherapy. For those who express fear of practicing SMBG in front 
of other people Ong et al. (2014) suggested counseling and peer support group referral 
while suggesting alternative site testing such as arm, abdomen, and thigh or the use of the 
lateral side of the finger for those who express anxiety over the use of needle and pain. 
Strengths and Limitations of the Project 
The results of this project are specific to the setting where the project took place. 
This project was conducted in an urban area, where participants have easy access to 
health care facilities. Therefore, the findings may not be applicable to other settings 
where health care services are more limited. The barriers to diabetes care questions were 
open-ended and prone to under-reporting, and additionally, because of the small sample 
and only one response was coded, it is possible that barriers may have been under-
recorded. On the other hand, it was my opinion that barriers reported by patients with 






Section 5: Dissemination Plan 
 The purpose of this quality improvement evaluation project was to identify 
barriers that prevent patients with T2DM to SMBG and to provide to the clinic strategies 
to overcome the barriers based on current evidence, in other to help the clinic to improve 
compliance to SMBG. A PowerPoint report or presentation that includes identified 
barriers, and strategies and recommendations to overcome the barriers to SMBG, will be 
provided to the clinic. The literature revealed that overcoming barriers to SMBG is a 
multidisciplinary approach that involves health care providers, patients and family 
members, nurses, and diabetes educators, and as a result a forum through the American 
Association of Diabetes Educators (AADE) is a suitable mean of dissemination as well as 
a publication to the journal of the American Diabetes Association (ADA), and the ANA 
journal known as American Nurse Today. 
Analysis of Self  
My first job as a registered nurse in 2009 was in the home health care 
organization, and as a home health nurse, patient education was a key component of my 
job description. The home health care environment shaped my early experience with 
patient non-adherence to home monitoring of blood glucose known as SMBG.  As a 
nurse practitioner and primary care provider since 2014, I encountered patients with 
chronic diseases seeking medical attention, and I provided them the best care at my level 
of training, knowledge, and education. In 2015, I enrolled in the doctor of nursing 
practice (DNP) program in pursuit of higher education. During the practicum activity, I 
was reviewing patients’ charts when I realized that the blood glucose log given to the 
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patient with T2DM to record their home monitoring of blood glucose was not filled out 
completely. The clinic providers decided to initiate a quality improvement project to 
understand the reasons that prevent patients with T2DM to adhere to the recommended 
SMBG. DNP graduates must be proficient in quality improvement strategies and in 
creating and sustaining changes at the organizational and policy level (AACN, 2006). 
As a postgraduate student, I plan to continue serving my population as their primary care 
provider focusing in applying evidence-based practice I gained from my project as related 
to overcoming barriers to SMBG. I will use a multidisciplinary approach when needed 
with patient with T2DM. I will use the same strategy to overcome barriers that prevent 
patients with chronic diseases to adhere to any recommended self-care behavior in my 
clinic.  
Researching the literature to identify barriers that prevent patient with T2DM to 
SMBG was challenging and complex. I used different databases with different 
combinations of key words to find the literature of interest. The experience I gained 
during the process of literature review helped me during the thematic coding of the 
patient’s response to the questionnaire. Researching the literature to overcome identified 
barriers give me more insight and cues to action about developing a holistic and 
individual strategies that may help providers improve adherence to SMBG. 
Summary 
SMBG is one of the most important skills in diabetes self-management and 
understanding and addressing barriers that prevent patients with T2DM to comply with 
SMBG may improve the patient adherence to SMBG and health outcome. The analysis of 
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the quality improvement project deidentified data given to me by the medical director of 
the clinic revealed that barriers that prevent patient with T2DM to SMBG were the cost 
of the supply, the lack of social support, the lack of diabetes education, and the patient’s 
emotion. The following recommendations were provided to the clinic: (a) Before 
ordering the use and frequency of SMBG, the heath care provider (HCP) may consider to 
identify patients ‘psychological and emotional needs, clinical, financial, and social 
support; (b) the HCP may consider to provide clear education and communication on the 
different purposes of SMBG, the treatment goals and strategies, and empower patients to 
interpret their blood glucose reading, and to recognize the symptom of abnormal 
glycemic; (c) the HCP may consider to ensure that the glucose meters prescribed to 
patients with T2DM are compatible with the testing strips covered under the lowest tier 
formulary of their health plans, or encourage them to seek out glucose monitoring kits 
that use the lower cost testing strips; (d) the HCP may consider to refer patients to a 
diabetes self- management education (DSME) program or diabetes support group;  (e) the 
HCP may consider to remind patient that SMBG is a means to an end, not a goal in itself, 
avoid interpreting BG values as failures;  (f) the HCP may consider to be sensitive to the 
anxiety that surround SMBG result, teach alternative site testing; and (g) the HCP may 
offer the Diabetes Fear of Injecting and Self-testing Questionnaire (D-FISQ) for 
determining the level of anxiety and the need for psychotherapy (Snoek et al., 2008).  
Collaboration among the entire diabetes care community is needed to facilitate the design 
of better patient-centered disease management programs that will ensure that monitoring 
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is performed and used to its fullest advantage which may result in improved patient 
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